Literature DB >> 22267760

Community-acquired pneumonia in outpatients: aetiology and outcomes.

Catia Cillóniz1, Santiago Ewig, Eva Polverino, Maria Angeles Marcos, Elena Prina, Jacobo Sellares, Miquel Ferrer, Mar Ortega, Albert Gabarrús, Josep Mensa, Antoni Torres.   

Abstract

The purpose of this study was to establish the microbial aetiology and outcomes of patients with community-acquired pneumonia (CAP) treated as outpatients after presenting to a hospital emergency care unit. A prospective observational study was carried out in the Hospital Clinic of Barcelona (Barcelona, Spain). All consecutive cases of CAP treated as outpatients were included. 568 adult outpatients with CAP were studied (mean ± SD age 47.2 ± 17.6 yrs; 110 (19.4%) were aged ≥ 65 yrs). Aetiological diagnoses were established in 188 (33.1%) cases. Streptococcus pneumoniae was the most frequent pathogen followed by Mycoplasma pneumoniae and respiratory viruses. Legionella was detected in 13 (2.3%) cases. More than one causative agent was found in 17 (9.0%) patients. Mortality was low (three (0.5%) patients died) and other adverse events were rare (30 (5.2%) patients had complications, 13 (2.3%) were re-admitted and treatment failed in 13 (2.3%)). Complications were mostly related to pleural effusion and empyema, and re-admissions and treatment failures to comorbidities. Outpatients with CAP have a characteristic microbial pattern. Regular antipneumococcal coverage remains mandatory. Treatment failures and re-admissions are rare and may be reduced by increased attention to patients requiring short-term observation in the emergency care unit and in the presence of pleural effusion and comorbidities.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22267760     DOI: 10.1183/09031936.00168811

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  22 in total

Review 1.  Community-acquired pneumonia: identification and evaluation of nonresponders.

Authors:  João Gonçalves-Pereira; Catarina Conceição; Pedro Póvoa
Journal:  Ther Adv Infect Dis       Date:  2013-02

Review 2.  Community-acquired pneumonia related to intracellular pathogens.

Authors:  Catia Cillóniz; Antoni Torres; Michael Niederman; Menno van der Eerden; James Chalmers; Tobias Welte; Francesco Blasi
Journal:  Intensive Care Med       Date:  2016-06-08       Impact factor: 17.440

Review 3.  The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.

Authors:  Mao Wang; Alex Gauthier; LeeAnne Daley; Katelyn Dial; Jiaqi Wu; Joanna Woo; Mosi Lin; Charles Ashby; Lin L Mantell
Journal:  Antioxid Redox Signal       Date:  2019-07-11       Impact factor: 8.401

Review 4.  Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis.

Authors:  Christian Marchello; Ariella Perry Dale; Thuy Nhu Thai; Duk Soo Han; Mark H Ebell
Journal:  Ann Fam Med       Date:  2016-11       Impact factor: 5.166

5.  Characterization of the Anti-Inflammatory Capacity of IL-10-Producing Neutrophils in Response to Streptococcus pneumoniae Infection.

Authors:  Liliana A González; Felipe Melo-González; Valentina P Sebastián; Omar P Vallejos; Loreani P Noguera; Isidora D Suazo; Bárbara M Schultz; Andrés H Manosalva; Hernán F Peñaloza; Jorge A Soto; Dane Parker; Claudia A Riedel; Pablo A González; Alexis M Kalergis; Susan M Bueno
Journal:  Front Immunol       Date:  2021-04-28       Impact factor: 8.786

Review 6.  Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients.

Authors:  Jesús López-Alcalde; Ricardo Rodriguez-Barrientos; Jesús Redondo-Sánchez; Javier Muñoz-Gutiérrez; José María Molero García; Carmen Rodríguez-Fernández; Julio Heras-Mosteiro; Jaime Marin-Cañada; Jose Casanova-Colominas; Amaya Azcoaga-Lorenzo; Virginia Hernandez Santiago; Manuel Gómez-García
Journal:  Cochrane Database Syst Rev       Date:  2018-09-06

7.  Evaluation of yield of currently available diagnostics by sample type to optimize detection of respiratory pathogens in patients with a community-acquired pneumonia.

Authors:  Elisabeth G W Huijskens; John W A Rossen; Jan A J W Kluytmans; Adri G M van der Zanden; Marion Koopmans
Journal:  Influenza Other Respir Viruses       Date:  2013-08-20       Impact factor: 4.380

Review 8.  A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults.

Authors:  James D Chalmers; James Campling; Alison Dicker; Mark Woodhead; Harish Madhava
Journal:  BMC Pulm Med       Date:  2016-05-11       Impact factor: 3.317

9.  Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain).

Authors:  Antoni Sicras-Mainar; Jordi Ibáñez-Nolla; Isabel Cifuentes; Pablo Guijarro; Ruth Navarro-Artieda; Lorenzo Aguilar
Journal:  BMC Infect Dis       Date:  2012-11-01       Impact factor: 3.090

Review 10.  Major advances in managing community-acquired pneumonia.

Authors:  Waseem Asrar Khan; Mark Woodhead
Journal:  F1000Prime Rep       Date:  2013-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.